SRx Health cancels 125M shares after $15.23M Series A preferred redemption
SRx Health Solutions redeemed 17,500 Series A Preferred shares, cancelling roughly 125 million common shares after raising $15.23 million in October 2025. The move reduces potential dilution and boosts balance sheet flexibility to pursue M&A or return capital to shareholders.
1. Preferred Stock Redemption
SRx Health Solutions redeemed 17,500 shares of its Series A Preferred Stock, representing conversion rights to approximately 125 million common shares. The Series A issuance had raised $15.23 million in October 2025 through private placement.
2. Balance Sheet and Share Count Impact
The cancellation of 125 million common shares removes potential dilution from the capital structure, reducing the outstanding share count and enhancing earnings per share potential. This action strengthens financial flexibility for capital allocation or shareholder returns.
3. Strategic Outlook
The company will file its fiscal Q1 10-Q on February 13, 2026 and remains open to evaluating M&A opportunities or capital returns using the improved balance sheet. No immediate transactions have been disclosed, as management focuses on strategic flexibility.